Applications published 18 July 2007

Medicament delivery system
Curtis, Robert John 1807016*

Preparation of chitin and derivatives thereof for cosmetic and therapeutic use
Mavi Sud 1807017*

In situ controlled release drug delivery system
University if Iowa Research Foundation 1807018*

Reverse micells based on phytosterols and acylglycerols and therapeutic uses thereof
Denderah Pharm 1807046*

Sodium ascorbate solubilisate
Aquanova German Solubilisate Technologies 1807047*

Reverse micelle compsns for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation
Medesis Pharma 1807048*

Spontaneously dispersible pharmaceutical compsns
Novartis; Novartis-Pharma 1807049*

Improvements in or relating to pharmaceutical compsns comprising an oligonucleotide as an active agent
novosom 1807050*

Compsns and methods for stabilising liposomal camptothecin formulations
Inex Pharmaceuticals 1807051*

Liposomal formulation of peptide boronic acids compounds
Alza Corp 1807052*

Liposomal formulation of bortezomib (PS-341)
Alza Corp 1807053*

Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
Expression Genetics 1807054*

Process for forming amorphous atorvastatin
Warner-Lambert 1807055*

Segmented device for the delayed release of molecules in a tangential direction through thin films and uses thereof
Capsulation Nanoscience 1807056*

Aliphatic amine polymer salts for tableting
Genzyme 1804058*

Tablets with site time-controlled gastrointestinal release of active ingredient
Nitec Pharma 1807058*

Lercanidipine capsules
Recordati Ireland; Recordati Industria Chimica e Farmaceutica 1807059*

Anisometric particles in the form of nanofibres/mesofibres, nanopipes/mesopipes. nanobands/mesobands, and the curved or branched variations thereof
Philipps-Universitaet Marburg; Justus-Liebig-Universitaet Giessen 1807060*

Osteogenic oligonucleotides and uses thereof
Immunotech 1807061*

Use of androgens to reduce the likelihood of acquiring or to treat skin aging
Endorecherche 1807062*

Pharmaceutical compsns comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type 1, obesity and related conditions
Solvay Pharmaceuticals 1807063*

Cyanoacrylate monomer formulation containing diiodomethyl-P-tolylsulphone and hydroxydiphenyl ether
Ethicon 1807064*

Methods and compsns for treating nephrogenic diabetes insipidus
University of Utah Research Foundation 1807065*

Combination of DPP-IV inhibitor, PPAR antidiabetic and metformin
Novartis; Novartis-Pharma 1807066*

Sphingosine kinase activator and skin disease treating agent comprising the same
Neopharm 1807067*

Compsn comprising acetaminophen, caffeine and optionally aspirin together with an alkaline agent for enhanced absorption
Novartis; Novartis-Pharma 1807068*

Methods for regulating weight and size of animals with glycine
Oragenics 1807069*

Combination of substituted azetidinones and CB1 antagonists
Schering 1807070*

Antipyretic compsns and methods
DOV Pharmaceutical 1807071*

Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
Eli Lilly 1807072*

Heterocyclic indanone potentiators of metabotropic glutamate receptors
Merck 1807073*

Mediators of hedgehog signaling pathways, compsns and uses related thereto
Curis, Genetech 1807074*

P13 kinase gamma inhibitors for the treatment of anaemia
Applied Research Systems 1807075*

N-pyridin-3-yl)-2-phenylbutanamides as androgen receptor modulators
Merck 1807076*

Inhibitors of C-FMS kinase
Janssen Pharmaceutica 1807077*

Diaminoalkane aspartic protease inhibitors
Vitae Pharmaceuticals 1807078*

Treating osteoarthritis and dosing regimen for arzoxifene
Eli Lilly 1807079*

Use of unsaturated quionoline or naphthalene derivatives as medicaments
AstraZeneca 1807080*

Cyclohexyldiamines as selective alpha 1A/1D adrenoreceptor antagonists for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms
Janssen Pharmaceutica 1807081*

Factor XA compounds
Janssen Pharmaceutica 1807082*

Use of pirlindole for the treatment of diseases which are characterised by proliferation FO T-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
Switch Biotec 1807083*

Use of pyrrolopyrazine derivatives for the production of medicaments for the treatment of muscoviscidosis and diseases related to protein addressing errors in cells
Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers 1807084*

Heterocyclic derivatives and their use as stearoyl-CoA desturase inhibitors
Xenon Pharmaceuticals 1807085*

Use of dipyridamole in combination with antithrombitics for treatment and prevention of thromboembolic diseases
Boehringer Ingelheim International 1807086*

Inhibitors of acetylcholinesterase for treating skin diseases
Snorrason, Emir 1807087*

Formulations of [1,4]diazepino[6,7-1-IJ]quinoline derivatives
Wyeth 1807088*

Methods of using fatty-acid esters of estrogens and serotonin reuptake inhibiting compounds for reducing the body weight of a mammal and compsns containing the same
Oleoyl-Estrone Developments 1807089*

Process for the preparation of ibandronate
F Hoffmann-La Roche 1807090*

Novel use of ligands specific to FEX-2 polypeptide
Kyungpook National University Industry-Academic Cooperation Foundation 1807091*

Biodegradable linkers for molecular therapies
The Children's Hospital of Philadelphia 1807092*

Antisense modulation of PTP1B expression
Isis Pharmaceuticals 1807093*

Therapeutic use of CPG oligodoxynucleotide for skin disease
Bio Clue & Solution; Inst of Medical Science Catholic Uni; Kim, Tae-Yoon; Shin, Dong-Heon 1807094*

Method and medicament for sulphated polysaccharide treatment of heparin-induced thrombocytopenia (HIT) syndrome
Paringenix 1807095*